The American Journal of Medicine
Volume 111, Issue 8 , Pages 593-601 , 1 December 2001

Which colon cancer screening test? A comparison of costs, effectiveness, and compliance

  • Sandeep Vijan, MD, MS

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Sandeep Vijan, MD, MS, Veterans Health Services Research and Development, PO Box 130170, Ann Arbor, Michigan 48113-0170 USA
    • The Veterans Affairs Center for Practice Management and Outcomes Research (SV, TPH, RAH), Ann Arbor, Michigan, USA
    • Department of Internal Medicine (SV, TPH, RAH), University of Michigan, Ann Arbor, Michigan, USA
    • ,
  • Erica W Hwang, MD

      Affiliations

    • Department of Internal Medicine, Georgetown University Medical Center (EWH), Washington, DC, USA
    • ,
  • Timothy P Hofer, MD, MS

      Affiliations

    • The Veterans Affairs Center for Practice Management and Outcomes Research (SV, TPH, RAH), Ann Arbor, Michigan, USA
    • Department of Internal Medicine (SV, TPH, RAH), University of Michigan, Ann Arbor, Michigan, USA
    • ,
  • Rodney A Hayward, MD

      Affiliations

    • The Veterans Affairs Center for Practice Management and Outcomes Research (SV, TPH, RAH), Ann Arbor, Michigan, USA
    • Department of Internal Medicine (SV, TPH, RAH), University of Michigan, Ann Arbor, Michigan, USA

Received 14 February 2001 ,Revised 14 August 2001 ,Accepted 23 August 2001.

References 

  1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin. 1996;46:5–27
  2. Mandel JS, Bond JH, Church TR, et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365–1371
  3. Kronborg O, Fenger C, Olsen J, et al.  Randomised study of screening for colorectal cancer with faecal-occult blood test. Lancet. 1996;348:1467–1471
  4. Hardcastle JD, Chamberlain JO, Robinson MHE, et al.  Randomised controlled trial of faecal-occult blood screening for colorectal cancer. Lancet. 1996;348:1472–1477
  5. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653–657
  6. Newcomb PA, Norfleet RG, Storer BE, et al.  Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572–1575
  7. Wagner JL, Tunis S, Brown M, et al.  Cost effectiveness of colorectal cancer screening in average-risk adults. In:  Young GP,  Rozen P,  Levin B editor. Prevention and Early Detection of Colorectal Cancer. Philadelphia: WB Saunders; 1996;p. 321–341
  8. Lieberman D. Cost effectiveness of colon cancer screening. Am J Gastroenterol. 1991;86:1789–1794
  9. Lieberman D. Cost effectiveness model for colon cancer screening. Gastroenterology. 1995;109:1781–1790
  10. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954–1961
  11. Sonnenberg A, Delco F, Inadomi JM. Cost effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000;133:573–584
  12. Solomon MJ, McLeod RS. Periodic health examination, 1994 update (2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination). Can Med Assoc J. 1994;150:1961–1970
  13. Winawer SJ, Fletcher RH, Miller L, et al.  Colorectal cancer screening (clinical guidelines and rationale). Gastroenterology. 1997;112:594–642
  14. Wagner JL, Herdman RC, Wadhwa S. Cost effectiveness of colorectal cancer screening in the elderly. Ann Intern Med. 1991;115:807–817
  15. Eddy DM. Screening for colorectal cancer. Ann Intern Med. 1990;113:373–384
  16. Loeve F, Brown ML, Boer R, et al.  Endoscopic colorectal cancer screening (a cost-saving analysis). J Natl Cancer Inst. 2000;92:557–563
  17. Khandker RK, Dulski JD, Kilpatrick JB, et al.  A decision model and cost effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care. 2000;16:799–810
  18. Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States?. Am J Public Health. 1995;85:840–842
  19. Brown ML, Potosky AL, Thompson GB, Kessler LG. The knowledge and use of screening tests for colorectal and prostate cancer (data from the 1987 National Health Interview Survey). Prev Med. 1990;19:562–574
  20. Elwood JM, Ali G, Schlup MM, et al.  Flexible sigmoidoscopy or colonoscopy for colorectal screening (a randomized trial of performance and acceptability). Cancer Detect Prev. 1995;19:337–347
  21. Lieberman D. Endoscopic colon screening (is less more?). Gastroenterology. 1996;111:1385–1389
  22. Rogge JD, Elmore MF, Mahoney SJ, et al.  Low-cost, office-based, screening colonoscopy. Am J Gastroenterol. 1994;89:1775–1780
  23. Winawer SJ, Zauber AG, Ho MN, et al.  Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med. 1993;329:1977–1981
  24. Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer. 1975;36:2251–2270
  25. Eide TJ. Remnants of adenomas in colorectal carcinomas. Cancer. 1983;51:1866–1872
  26. Morson BC. The evolution of colorectal carcinoma. Clin Radiol. 1984;35:425–431
  27. Johnson DA, Gurney MS, Volpe RJ, et al.  A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol. 1990;85:969–974
  28. DiSario JA, Foutch PG, Mai HD, et al.  Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol. 1991;86:941–945
  29. Rickert RR, Auerback O, Garfinkel L, et al.  Adenomatous lesions of the large bowel (an autopsy survey). Cancer. 1979;43:1847–1857
  30. Blatt LJ. Polyps of the colon and rectum (incidence and distribution). Dis Colon Rectum. 1961;4:277–282
  31. Arminski TC, McLean W. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations. Dis Colon Rectum. 1964;7:249–261
  32. Ries LAG, Kosary CL, Hankey BF, et al.  SEER Cancer Statistics Review—1973–1996. Bethesda: National Cancer Institute; 1999;
  33. Myers M, Ries LAG. Cancer patient survival rates (SEER program results for 10 years of follow-up). CA Cancer J Clin. 1989;39:21–32
  34. Ahlquist DA, Wieand HS, Moertell CG, et al.  Accuracy of fecal occult blood screening for colorectal neoplasia. JAMA. 1993;269:1262–1267
  35. Mandel JS, Bond JH, Bradley M, et al.  Sensitivity, specificity, and positive predictivity of the hemoccult test in screening for colorectal cancers. Gastroenterology. 1989;97:597–600
  36. Macrae FA, St John DJB. Relationship between patterns of bleeding with hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology. 1982;82:891–898
  37. Crowley ML, Freeman LD, Mottet MD, et al.  Sensitivity of guaiac-impregnated cards for the detection of colorectal neoplasia. J Clin Gastroenterol. 1983;5:127–130
  38. Rex DK, Lehman GA, Hawes RH, et al.  Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology. 1991;100:64–67
  39. Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasm (sensitivity, specificity, and predictive value). Ann Intern Med. 1990;12:328–333
  40. Niv Y, Sperber AD. Sensitivity, specificity, and predictive value of fecal occult blood testing (hemoccult II) for colorectal neoplasia in symptomatic patients (a prospective study with total colonoscopy). Am J Gastroenterol. 1995;90:1974–1977
  41. Foutch PG, Mai H, Pardy K, et al.  Flexible sigmoidoscopy may be ineffective for secondary prevention of colorectal cancer in asymptomatic, average-risk men. Dig Dis Sci. 1991;36:924–928
  42. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol. 1991;86:946–951
  43. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658–662
  44. Rex DK, Cutler CS, Lemmel GT, et al.  Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997;112:24–28
  45. Hixson LJ, Fennerty MB, Sampliner RE, Garewal HS. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc. 1991;37:125–127
  46. Rex DK. Colonoscopy (a review of its yield for cancers and adenomas by indication). Am J Gastroenterol. 1995;90:353–365
  47. Castiglione G, Mazzotta A, Grazzini G. Sensitivity of screening sigmoidoscopy for proximal colorectal tumours. Lancet. 1995;345:726–727
  48. Zarchy TM, Ershoff D. Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy?. Gastroenterology. 1994;106:1501–1504
  49. Achkar E, Carey W. Small polyps found during fiberoptic sigmoidoscopy in asymptomatic patients. Ann Intern Med. 1988;109:880–883
  50. Habr-Gama A, Waye JD. Complications and hazards of gastrointestinal endoscopy. World J Surg. 1989;13:193–201
  51. Macrae FA, Tan KG, Williams CB. Towards safer colonoscopy (a report on the complications of 5000 diagnostic or therapeutic colonoscopies). Gut. 1983;24:376–383
  52. Waye JD, Lewis BS, Yessayan S. Colonoscopy (a prospective report of complications). J Clin Gastroenterol. 1992;15:347–351
  53. Eddy DM, Nugent FW, Eddy JF, et al.  Screening for colorectal cancer in a high-risk population. Gastroenterology. 1987;92:682–692
  54. Department of Health, and Human Services HCFA . Medicare program; revisions to payment policies and five-year review of and adjustments to the relative value units under the physician fee schedule for calendar year 2000 and physician volume performance standard rates of increase for federal fiscal year 1999, notice. Fed Regist. 1999;64:59379–59428
  55. Fireman BH, Quesenberry CP, Somkin CP, et al.  Cost of care for cancer in a health maintenance organization. Health Care Financing Rev. 1997;18:51–76
  56. Baker MS, Kessler LG, Smucker RC. Analysis of the continuous Medicare history sample file: the cost of treating cancer. In: Proceedings of the Annual Meeting of the American Cancer Society. Scientific Session; May 1987, San Diego, California. New York: American Cancer Society; 1987;
  57. National Center for Health Statistics. Vital Statistics of the United States, 1991. Mortality. Vol. 2 (part B). Washington, DC: Public Health Service; 1995
  58. Cauffman JG, Hara JH, Rasgon IM, Clark VA. Flexible sigmoidoscopy in asymptomatic patients with negative fecal occult blood tests. J Fam Pract. 1992;34:281–286
  59. Squillace S, Berggreen P, Jaffe P, et al.  A normal initial colonoscopy after age 50 does not predict a polyp-free status for life. Am J Gastroenterol. 1994;89:1156–1159
  60. Rex DK, Cummings OW, Helper DJ, et al.  5-Year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. Gastroenterology. 1996;111:1178–1181
  61. Rex DK, Lehman GA, Ulbright TM, et al.  The yield of a second screening flexible sigmoidoscopy in average-risk persons after one negative examination. Gastroenterology. 1994;106:593–595
  62. Bond JH. Polyp guideline (diagnosis, treatment, and surveillance for patients with nonfamilial colorectal polyps). Ann Intern Med. 1993;119:836–843
  63. Bond JH. Follow-up after polypectomy (consensus?). Eur J Cancer. 1995;31A:1141–1144
  64. Winawer SJ, Zauber AG, O’Brien MJ, et al.  Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med. 1993;328:901–905
  65. Bhattacharya I, Sack EM. Screening colonoscopy (the cost of common sense). Lancet. 1996;347:1744–1745
  66. Neugut AI, Forde KA. Screening colonoscopy (has the time come?). Am J Gastroenterol. 1988;83:295–297
  67. Lieberman D. Screening colonoscopy (has the time come?). Prim Care. 1995;22:501–511
  68. Ransohoff DF, Lang CA. Using colonoscopy to screen for colorectal cancer. Am J Gastroenterol. 1994;89:1765–1766
  69. Byers T, Levin B, Rothenberger D, et al.  American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer (update 1997). CA Cancer J Clin. 1997;47:154–160
  70. Fletcher RH. The end of barium enemas?. N Engl J Med. 2000;342:1823–1824
  71. Winawer SJ, Stewart ET, Zauber AG, et al.  A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. N Engl J Med. 2000;342:1766–1772
  72. Salzmann P, Kerlikowske K, Phillips K. Cost effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med. 1997;127:955–965

☆ Timothy P. Hofer, MD, MS, and Sandeep Vijan, MD, MS, are recipients of the Veterans Affairs Health Services Research and Development Career Development Award, Ann Arbor, Michigan.

PII: S0002-9343(01)00977-9

The American Journal of Medicine
Volume 111, Issue 8 , Pages 593-601 , 1 December 2001

Article Tools

* Image Usage & Resolution